RCA
FBT icon

Resonant Capital Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Resonant Capital Advisors’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Buy
+975
New +$210K 0.01% 461
2026
Q1 		– Sell
-975
Closed -$201K – 499
2025
Q4 		$201K Buy
+975
New +$195K 0.01% 427

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Resonant Capital Advisors's FBT Position: Q2 2026 in Review

Resonant Capital Advisors opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026: 975 shares worth $242K. The stake represents 0.01% of the portfolio and ranks #461 among its holdings. This is a return to the name: Resonant Capital Advisors previously reported a position in FBT as recently as Q4 2025.

Resonant Capital Advisors first reported a position in FBT in Q4 2025 and has held it in 2 quarters since. 340 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Resonant Capital Advisors held 975 shares of First Trust NYSE Arca Biotechnology Index Fund worth $242K as of Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund was a new Resonant Capital Advisors position in Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Resonant Capital Advisors's portfolio in Q2 2026, its #461 holding.
  • Resonant Capital Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2025 and has held it in 2 quarters since.
  • 340 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.